- Home
- TUYA vs SPRY Comparison
TUYA vs SPRY Comparison
Compare TUYA & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TUYA
- SPRY
- Stock Information
- Founded
- TUYA 2014
- SPRY 2015
- Country
- TUYA China
- SPRY United States
- Employees
- TUYA N/A
- SPRY N/A
- Industry
- TUYA Computer Software: Prepackaged Software
- SPRY Biotechnology: Pharmaceutical Preparations
- Sector
- TUYA Technology
- SPRY Health Care
- Exchange
- TUYA Nasdaq
- SPRY Nasdaq
- Market Cap
- TUYA 1.7B
- SPRY 1.4B
- IPO Year
- TUYA 2021
- SPRY N/A
- Fundamental
- Price
- TUYA $2.35
- SPRY $15.69
- Analyst Decision
- TUYA
- SPRY Strong Buy
- Analyst Count
- TUYA 0
- SPRY 4
- Target Price
- TUYA N/A
- SPRY $28.75
- AVG Volume (30 Days)
- TUYA 2.3M
- SPRY 1.2M
- Earning Date
- TUYA 05-20-2025
- SPRY 08-05-2025
- Dividend Yield
- TUYA 4.59%
- SPRY N/A
- EPS Growth
- TUYA N/A
- SPRY N/A
- EPS
- TUYA 0.03
- SPRY N/A
- Revenue
- TUYA $311,642,000.00
- SPRY $97,122,000.00
- Revenue This Year
- TUYA $11.65
- SPRY N/A
- Revenue Next Year
- TUYA $13.06
- SPRY $140.40
- P/E Ratio
- TUYA $75.46
- SPRY N/A
- Revenue Growth
- TUYA 27.64
- SPRY 971120.00
- 52 Week Low
- TUYA $1.28
- SPRY $7.55
- 52 Week High
- TUYA $4.63
- SPRY $18.51
- Technical
- Relative Strength Index (RSI)
- TUYA 41.19
- SPRY 60.81
- Support Level
- TUYA $2.50
- SPRY $14.77
- Resistance Level
- TUYA $2.74
- SPRY $16.23
- Average True Range (ATR)
- TUYA 0.14
- SPRY 0.73
- MACD
- TUYA -0.03
- SPRY 0.12
- Stochastic Oscillator
- TUYA 4.00
- SPRY 84.68
About TUYA Tuya Inc. each representing one
Tuya Inc is an IoT cloud development platform with a mission to build an IoT developer ecosystem and enable everything to be smart. The Company has pioneered a purpose-built IoT cloud development platform that delivers a full suite of offerings, including platform-as-a-service (PaaS) and Software-as-a-service (SaaS), to businesses and developers. Through its IoT cloud development platform, it has enabled developers to activate a vibrant IoT ecosystem of brands, OEMs, partners, and end users to engage and communicate through a broad range of smart devices. The company's revenue is derived from the PRC.
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.